These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2172593)

  • 1. [Effects of low molecular weight heparin as an anti-coagulant for hemodialysis].
    Akizawa T; Kanamori N; Koshikawa S
    Rinsho Byori; 1990 Jul; Suppl 86():171-6. PubMed ID: 2172593
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of low molecular weight heparin and unfractionated heparin in patients on maintenance hemodialysis].
    Noguchi M; Izumi K; Deguchi K; Endoh T; Tsuda M; Shirakawa S
    Rinsho Byori; 1990 Jul; Suppl 86():177-83. PubMed ID: 2172594
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of low-molecular weight heparin during hemodialysis].
    Kalinowski M; Pawlak K; Myśliwiec M; Popławski A
    Pol Merkur Lekarski; 1997 Jan; 2(9):208-10. PubMed ID: 10907031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
    Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
    Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of low molecular weight heparin on the hemodialysis model in dogs].
    Hamano S; Sakuragawa N
    Rinsho Byori; 1990 Jul; Suppl 86():165-70. PubMed ID: 2172592
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of anticoagulation efficacy and clinical safety between imported and domestically manufactured low-molecular-weight heparin during hemodialysis.
    Liu ZQ; Wang L
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct; 22(10):942-3. PubMed ID: 12377628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Present opinions concerning the administration of low molecular weight heparins in hemodialysis patients].
    Drozdz M; Kowalczyk-Michałek M; Kraśniak A; Sułowicz W
    Przegl Lek; 2005; 62(4):257-9. PubMed ID: 16229247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of low molecular weight heparin and standard heparin in hemodialysis.
    Bambauer R; Rücker S; Weber U; Köhler M
    ASAIO Trans; 1990; 36(3):M646-9. PubMed ID: 2174689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalent effective doses of heparin and low molecular weight heparin(oid)s in haemodialysis for chronic renal failure.
    Lane DA; Ireland H; Tew CJ; Flynn A; Curtis JR
    Acta Chir Scand Suppl; 1988; 543():101-4. PubMed ID: 2847457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticoagulation in hemodialysis with a single dose of low molecular weight heparin].
    Vukusich A; Avalos C; Orellana G; Cifuentes C; Rivas J; Calderón F
    Rev Med Chil; 1995 Jun; 123(6):735-41. PubMed ID: 8525227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-factor Xa determination in blood: a new method for controlling heparin therapy.
    Harenberg J; Haaf B; Schäfer M; Dempfle CE; Stehle G; Heene DL
    Semin Thromb Hemost; 1993; 19 Suppl 1():79-85. PubMed ID: 8395736
    [No Abstract]   [Full Text] [Related]  

  • 12. Rationale for the use of a low molecular weight heparin during hemodialysis with polysulphone membrane in uremic patients.
    Moia M; Graziani G; Tenconi PM; Martinelli I; Ponticelli C
    Ann Ital Med Int; 1997; 12(2):67-71. PubMed ID: 9284597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy anticoagulation in extracorporeal hemodialysis by simultaneous administration of low-dose prostacyclin and low molecular weight heparin.
    Camici M; Giordani R; Morelli E; Meriggioli M; Balestri PL; Barsotti G; Sagripanti A
    Minerva Med; 1998; 89(11-12):405-9. PubMed ID: 10212664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro anticoagulation monitoring of low-molecular-weight heparin.
    Wang JQ; Shi XB; Yang JG; Hu DY
    Chin Med J (Engl); 2009 May; 122(10):1199-202. PubMed ID: 19493471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
    Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
    Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparin for routine hemodialysis.
    Davenport A
    Hemodial Int; 2008 Oct; 12 Suppl 2():S34-7. PubMed ID: 18837768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparin--does it favourably affect lipid levels?
    Stenvinkel P
    Nephrol Dial Transplant; 1995; 10(1):16-8. PubMed ID: 7724021
    [No Abstract]   [Full Text] [Related]  

  • 18. A single dose of a low molecular weight heparin fragment for anticoagulation during hemodialysis.
    Ljungberg B; Blombäck M; Johnsson H; Lins LE
    Clin Nephrol; 1987 Jan; 27(1):31-5. PubMed ID: 3815906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparins should be used with caution in patients with chronic kidney disease.
    Gallieni M; Cozzolino M; Ronga C; Brancaccio D
    Nat Clin Pract Nephrol; 2008 Sep; 4(9):488-9. PubMed ID: 18612327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.